Clinical significance & Methods

Slides:



Advertisements
Similar presentations
ALT/sGPT activity xiaoli.
Advertisements

Enzymes Lab # 7. Enzymes: Definition Enzymes are highly specific biologic catalysts that greatly speed up the rate of a chemical reaction occurring in.
Faculty of nursing CHEM 203 Biochemistry UNIT VIII Diagnostic Enzymes Dr.Ola Fouad Talkhan.
CLINICAL CHEMISTRY (MLT 301) NONPROTEIN NITROGEN (NPN) LECTURE ONE
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez
Determination of plasma enzymes using the clinical analyzer
I. General Description of Enzymes
1 Methods for the determination in serum and urine Dr. Essam H. Aljiffri.
1 Serum Enzymes in Disease Dr. Essam H. Aljiffri.
AST, ALT & ALP Lab. 5.
Enzymes in Body Fluids Lecture outline
Supervised by: Associate professor: Dr. Alaa Abdel Salam Dr. Alaa Abdel Salam Done by:- Done by:- Asma Al – Rashoud Asma Al – Rashoud
Creatine Metabolism Energy to Skeletal Muscles Lecture-2.
Enzymes Part 1 M. Zaharna Clin. Chem
DR. ABDULRAHMAN AL-AJLAN MYOCARDIAL INFARCTION. Introduction The heart is a muscular organ whose function is pumping of blood around the body. It consists.
(clinical biochemistry of enzymes)
Lecture 5. Infarction The process by which necrosis results from ischemia is called infarction Ischemic necrosis of myocardial cells is one of the commonest.
1 Assay the Activity of Alkaline Phosphatase (ALP) in Serum (Disodium phenyl phosphate Method)
Enzymes in Clinical Diagnosis
Biochemistry II - Seminars
Enzymes Dr. Noha Soliman.
DESCRIPTION  Alkaline phosphatase (ALP) (EC ) catalyzes the hydrolysis of phosphate esters in an alkaline environment, resulting in the formation.
Alanine Transaminase.
Liver function tests Lecture 3.
By: H.Baniamerian Kermanshah university of medical science.
Aminotransferases. AMINOTRANSFERASES Definition – Interconversion of amino acids to 2-oxo-acids – Amino group donor – Amino group acceptor Aminotransferases.
Amino acid degradation Most of absorbed dietary amino acids are catabolized by 2 subsequent steps: I- Removal of α-amino group: α-amino group is removed.
Liver Function Tests. Tests Based on Detoxification and Excretory Functions.
Liver Function Tests (LFTs)
Biochemical markers in disease diagnosis
Clinical Enzymology Prepared by: Sr. Siti Norhaiza Bt Hadzir.
Serum biochemical parameters (ALT) (AST) assay Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015.
Enzymes Biochemistry (BMS) L.Noha Soliman.
Lab # PHL.  Phosphatases are enzymes which catalyze the splitting of phosphoric acid from mono-phosphate esters.  They are hydrolases.  Organic.
Methods of Enzyme Assay
ENZYMES BY DR. MARYJANE.
Enzyme Clinical Application
Introduction Enzymes are usually proteins that act as catalysts, compounds that increase the rate of chemical reactions. They bind specifically to a substrate,
Cellular Biochemistry and Metabolism (CLS 333 ) Dr. Samah Kotb Nasr Eldeen Serum biochemical parameters (ALT) (AST) assay.
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
CLINICAL ENZYMOLOGY. Measurements of the activity of enzymes in plasma are of value in the diagnosis and management of a wide variety of diseases.
Enzymes AST, ALT & ALP Lab. 6.
Biochemical markers for diagnosis and follow up of disease
1 Enzymes Dr. Tagreed Osman. An enzyme is a protein catalyst that accelerates the speed of a chemical reaction by binding specifically to a substrate,
Isoenzymes Dr. Vidya.D Asst. Professor, College of Pharmacy,
Creatine Metabolism Energy to Skeletal Muscles Lecture-2.
Dr. Manal Basyouni Cardiac Markers 1Dr. Manal Basyouni.
Lab # 2 Liver Function Tests (LFTs) ALT&AST T.A. Bahiya M. Osrah.
Khadija Balubaid KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (BIOC 416) 2013 Liver Function profile (LFT) Enzymes.
Determination of plasma enzymes
Clinical usage of enzymes
Lab (2): Liver Function profile (LFT)
THE ISOENZYME PROFILE OF LACTATE DEHYDROGENASE Assaying the serum levels of lactate dehydrogenase (LDH) activity combined with the results of other clinically.
Methods of Enzyme Assay
Isoenzymes.
Isoenzymes Multiple forms of an enzyme which differ in physical and chemical properties and catalyze the same reaction as an enzyme. Isoenzymes are produced.
ALKALINE PHOSPHATASE This is a widely distributed enzyme which releases inorganic phosphate from many organic phosphomonoesters and also pyrophosphates.
Lab (2): Liver Function profile (LFT)
Enzymes in the Diagnosis of Pathology
Isoenzymes Multiple forms of an enzyme which differ in physical and chemical properties and catalyze the same reaction as an enzyme. Isoenzymes are produced.
biochemical markers for diagnosis and follow up of diseases
Cardiac enzymes and cardiac proteins
Determination of the enzyme ALT (SGPT) & AST activity in serum by enzymatic method using Biophotometer.
Enzymes.
Determination of plasma enzymes
Part 1 Liver enzyme(ALT-AST-ALP-GGT)
Enzymes.
Cardiac profile test.
Biochemical markers for diagnosis of diseases and follow up
Determination of plasma enzymes
Presentation transcript:

Clinical significance & Methods Enzymes Clinical significance & Methods

Measurements of enzymes in serum within a tissue enzymes as markers of disease, Injury to tissue releases cellular substances that can be used as plasma markers of tissue damage. enzyme release is highly specific for cell death in some settings.

Some enzymes are predominantly found in the specialized tissue while others, more widely distributed, have tissue specific isoenzymes or isoforms The timing of the enzyme's diagnostic window early indicators late indicators Several enzymes have diagnostic utility

Overlap occurs for some enzymes may be used for investigating disease in several organs.

Enzymes of clinical interest MUSCLE ENZYMES More commonly measured CK, LD CK; adenosine triphosphate: creatine N-phosphotransferase

Inhibitors excess Mg2+ Many metal ions, such as Mn2+ , Ca2+ , Zn2+ ,Cu2+ sulfhydryl-binding reagents Iodoacetate

The distribution of these isoenzymes in the various tissues CK is a dimer (B and M) the products of loci on chromosomes 14 and 19, respectively. BB (or CK-1), MB (or CK-2), and MM (or CK-3). numbered on the basis of their electrophoretic mobility, with the most anodal form receiving the lowest number. The distribution of these isoenzymes in the various tissues

Serum CK activity is subject to a number of physiological variations. Sex, age, muscle mass, physical activity, and race all interact to affect serum activities

Clinical Significance Serum CK activity is greatly elevated in all types of muscular dystrophy. may be increased long before the disease is clinically apparent. Serum CK activity characteristically falls as patients get older and as the mass of functioning muscle diminishes with the progression of the disease.

Long time Physical inactivity reduce serum CK Skeletal muscle that is diseased or damaged (fetal reversion) Renal failure , increase CK Serum CK activity demonstrates an inverse relationship with thyroid activity. Following a myocardial infarction MB isoenzyme

The assay of CK activity Coupled enzyme methods NADP+ to NADPH, monitored spectrophotometrically.

Methods for the Separation & Quantification of CK Isoenzymes CK activity in serum is relatively unstable and is rapidly lost during storage. Average stabilities are less than 8 hours at room temperature, 48 hours at 4°C, and 1 month at -20°C. Methods for the Separation & Quantification of CK Isoenzymes Electrophoresis & various immunological methods.

Enzymes of clinical interest Widely used enzymes Aspartate aminotransferases (AST) Alanine aminotransferases (ALT) ALP

The aminotransferases catalyze the interconversion of amino acids to 2-oxo-acids L-aspartate:2-oxoglutarate aminotransferase;AST L-alanine:2-oxoglutarate aminotransferase; ALT

Pyridoxal-5'-phosphate ↔ pyridoxamine-5' –phosphate Both the coenzyme-deficient apoenzymes and the holoenzymes may be present in serum. All factors affecting the rate of reaction must be optimized and controlled

Transaminases are widely distributed throughout the body.

Clinical Significance Liver disease is the most important cause of increased transaminase activity in serum. In most types of liver disease, ALT activity is higher than that of AST; exceptions alcoholic hepatitis, hepatic cirrhosis, and liver neoplasia. elevated even before the clinical signs and symptoms of disease

ALT is the more liver-specific enzyme. Peak values of transaminase activity occur between the 7th and 12th days Medications nonsteroidal antiinflammatory drugs, antibiotics. ALT is the more liver-specific enzyme. elevations of ALT activity persist longer than do those of AST activity.

After AMI, increased AST activity appears in serum AST activity also is increased in some types of muscle diseases Also serum CK Mitochondrial AST (m-AST) activity extensive liver cell degeneration and necrosis. the ratio between m-AST and total AST activities typical of alcoholic hepatitis

The increased AST activity might reflect decreased clearance Macro-AST

Measurement of Transaminase Activity coupling the transaminase reactions to specific dehydrogenase reactions. Pyruvate formed in the ALT reaction is reduced to lactate by LD.

The change in absorbance per minute (ΔAlmin) is proportional to the micromoles of NADH oxidized and in turn to micromoles of substrate transformed per minute. AST activity in serum is stable for up to 48 hours at 4°C. ALT stability is better maintained at -70°C.

Methods for the Separation & Quantification of AST Isoenzymes Reference Intervals AST; 31 U/L for women and 35 U/L for men Methods for the Separation & Quantification of AST Isoenzymes electrophoresis, selective inhibition, and immunoassays. anionic (cytoplasmic AST) and a cationic band (m-AST)

m-AST (healthy individuals ) About 5% to I0% of the activity of total AST in serum 3.0 U/L.

ALKALINE PHOSPHATASE ALP Orthophosphoric monoester phospho hydrolase alkaline optimum hydrolysis of a large variety of naturally occurring and synthetic substrates ALP activity is present in most organs of the body especially associated with membranes and cell surfaces In the mucosa of the small intestine and proximal convoluted tubules of the kidney, in bone (osteoblasts), liver, & placenta

ALP exists in multiple forms Metabolic function Lipid transport in the intestine Calcification process in bone ALP exists in multiple forms

activators of the enzyme, Inhibitors divalent ions, Zn2+ Inhibitors Phosphate, cyanide ions,… The ALP activity in the sera of healthy adults Liver Skeleton

Clinical Significance Common causes of elevation Liver Hepatobiliary disease bone Bone disease associated with increased osteoblastic activity Carcinoplacental isoenzymes derepression of the placental ALP gene non placental isoenzymes Modified forms of ALP

Determination of Alkaline Phosphatase Activity The rate of formation of 4-NP at 405 nm is monitored

Determination of Alkaline Phosphatase Activity Serum or heparinized plasma, free of hemolysis, should be used. Freshly collected serum or up to 4 hours RT* Frozen specimens; ALP activity increases kept at room temperature for 18 to 24 before assay *Room temperature

Reference Intervals ALP activities in serum vary with age.

Assays for ALP isoenzymes are needed when: Methods for the Separation and Quantification of Alkaline Phosphatase Isoenzymes Assays for ALP isoenzymes are needed when: the source of an elevated ALP in serum is not obvious to monitor the disease activity and the effect of appropriate therapies Electrophoretic mobility Stability to denaturation by heat or chemicals Response to the presence of selected Inhibitors

Improvement of electrophoretic separation anodal mobility, The liver, most rapidly Bone ALP, slightly lower Intestinal ALP Placental isoenzyme Discrete band overlying the diffuse bone fraction Improvement of electrophoretic separation treated briefly with neuraminidase Electrophoresis in the presence of wheat germ lectin

Placental ALP is heat stable Other evidences Immunological methods 65°C for 30 min Other evidences eg ;measurement of GGT Immunological methods Intestinal or placental ALPs.

Acid Phosphatase (ACP) Include all phosphatases that hydrolyze phosphate esters with an optimum pH of less than 7.0. Produced by Primarily, prostate gland, also found in erythrocytes, platelets, leukocytes, bone marrow, bone, liver, spleen, kidney, and intestine.

Acid Phosphatase (ACP) ACP is present in Lysosomes, Extra lysosomal The lysosomal and prostatic enzymes strongly inhibited by D-tartrate ions, the erythrocyte and bone isoenzymes are not inhibited.

Acid Phosphatase (ACP) Normal serum ACP The majority of the normally low ACP activity of (unhemolyzed) serum is of a Tartrate-resistant type (TR-ACP) Probably originates mainly in osteoclasts. Increased Physiologically in growing children Pathologically in conditions of increased osteolysis and bone remodeling. High concentrations of TR-ACP in serum Reflect increased osteoclastic activity, whether appropriate as in normal bone growth, or damaging

The only nonbone condition Gaucher's disease of spleen, a lysosomal storage disorder, elevated activities of TR-ACP are found in serum, abnormal macrophages in spleen and other tissues, overexpress ACP

Acid Phosphatase (ACP) ACP-determining genes At least four have been identified and mapped. ACPs are labile more than 30% of the ACP activity may be lost in 3 hours at room temperature. Acidification of the serum specimen to a pH below 6.5 aids in stabilizing the enzyme activity.

Acid Phosphatase Prostatic acid phosphatase (PAP), an optimum pH of 5 to 6, very labile at a pH of greater than 7.0 very labile at temperature greater than 37°C. Distinguished from other acid phosphatases by Using tartrate, Strongly inhibits the prostatic form. Select substrates that are more specific for PAP thymolphthalein monophosphate and β-naphthol phosphate. Hydrolyzed by PAP much more quickly

Acid Phosphatase The clinical use of PAP as a screening tool for prostate cancer. to help stage prostate cancer, to correlate with the prognosis of the disease, to monitor therapy. Elevated serum PAP may be seen in malignant conditions, osteogenic sarcoma, multiple myeloma, and bone metastases of other cancers. in some benign conditions, Osteoporosis, benign prostatic hyperplasia and hyperparathyroidism.

Acid Phosphatase The clinical use of PAP has been replaced by PSA PAP is not as sensitive as PSA for screening or for detection of early cancer. restricted to confirmation of metastatic prostate cancer and staging of prostate cancer. Currently the method of choice for PAP Measurement of enzymatic activity.

Acid Phosphatase Measurement of ACP Principle: Methods Continuous-monitoring methods of ACP activity Immunological methods Principle: Thymolphthalein monophosphate is hydrolyzed by prostatic ACP at pH 5.4 and 37°C. The reaction stopped after 30 min by addition of NaOH-Na2CO3 solution This develops the alkaline color of the liberated Thymolphthalein Measured at 595 nm

Acid Phosphatase Specimens: Serum should be immediately separated from erythrocytes and stabilized by the addition of acetic acid to lower the pH to 5.4 Under these conditions, ACP activity is maintained at room temperature for several hours, for up to a week if the serum is refrigerated, and for 4 months if stored at -20°C.

Acid Phosphatase Specimens: Hemolyzed serum specimens are contaminated with considerable amounts of the erythrocyte tartrate-resistant isoenzyme and should be rejected. Chylous sera should be avoided Interference with measurement due to turbidity

Acid Phosphatase